Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00402428 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
A Phase 3 study, sponsored by Human Genome Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,331
- Enrollment target
NCT00402428: Completed Phase 3 study, sponsored by Human Genome Sciences.
NCT00402428 is a Phase 3 study that has completed, run by Human Genome Sciences. The registered enrollment target is 1,331 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00402428, a Phase 3 study, has completed, sponsored by Human Genome Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,331 participants
- Enrollment target
Study Summary
This is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of albumin interferon alfa 2b (alb-IFN)in combination with ribavirin compared with peginterferon alfa-2a (PEGASYS or PEG-IFNa2a) in combination with ribavirin in subjects with chronic hepatitis C, genotype 1 who are IFNa treatment naive.
Interventions
- DRUG Ribavirin
- DRUG albumin interferon alfa-2b
- DRUG peginterferon alfa-2a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,331 participants |
| Start Date | 2006-12 |
| Est. Completion | 2009-02 |
| Phase | Phase 3 |
What the finished NCT00402428 record still lists
NCT00402428 is an interventional study that assigns participants to a tested intervention. Its 1,331 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (72% higher).
The record links to 0 conditions, and to 3 interventions - of which Ribavirin is the first listed.
NCT00402428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00402428 about?
NCT00402428 is a clinical study titled "Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients". This is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of albumin interferon alfa 2b (alb-IFN)in combination with ribavirin compared with peginterferon alfa-2a (PEGASYS or PEG-IFNa2a) in combination with ribavirin in subjects with chronic hepatitis C, genotype 1 who ar...
What is the current status of trial NCT00402428?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,331 participants. The study started on 2006-12. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00402428?
The interventions under investigation include: Ribavirin (DRUG), albumin interferon alfa-2b (DRUG), peginterferon alfa-2a (DRUG).
Who is sponsoring clinical trial NCT00402428?
This trial is sponsored by Human Genome Sciences, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00402428's enrollment target sits among peer trials
1,331 183rd of 2000 higher than 1,818 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05415761 · 1,332 participants · NA
Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care
- NCT05511298 · 1,332 participants
Empowering Students Project
- NCT06934876 · 1,332 participants
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
- NCT05536011 · 1,329 participants
WAKIX® (Pitolisant) Pregnancy Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia